Biomedicines 10 (9), 2306 (2022)
Higher strengths of oral semaglutide (25 mg and 50 mg) were studied in the OASIS clinical trial, and showed promising results, an average of 15.1% weight loss.* [2] *Oral semaglutide, 50 mg, over 68 weeks
Pairing L-carnitine with a balanced diet, regular training, and targeted performance-enhancing supplements can amplify results
Compounded medications are not FDA-approved finished drug products and are not FDA-approved generic equivalents of brand-name GLP-1 drugs
While short-acting versions like daily injections may better control postprandial glucose levels, they have largely been replaced by long-acting alternatives such as semaglutide (Ozempic and Wegovy) and tirzepatide (Mounjaro and Zepbound), which only require weekly injections
These medications have undergone extensive FDA review and have demonstrated consistent dosing and safety across large clinical trials